The FDA Approves Another Flu Vaccine
Posted on: Monday, 1 October 2007, 09:00 CDT
The U.S. Food and Drug Administration has approved Afluria, an additional seasonal influenza vaccine for people ages 18 and older.
The FDA said Afluria -- intended to protect adults from influenza type A and type B flu viruses -- brings the number of seasonal influenza manufacturers licensed in the U.S. market to six. They are expected to supply a record 132 million doses of influenza vaccine for the 2007-08 influenza season.
Afluria contains inactivated influenza viruses grown in chicken eggs, the FDA said. People allergic to eggs shouldn't receive Afluria.
Source: United Press International
Related Articles
- CSL Biotherapies Introduces Afluria Influenza Vaccine in US
- CSL Biotherapies Announces First Shipments of Afluria(R) Thimerosal-Free Influenza Vaccine for the 2008-2009 Flu Season
- Phase III U.S. Pivotal Study Results on CSL Biotherapies' Afluria(R) Published in Vaccine
- CSL Biotherapies Announces Afluria(R) Pre-Booking Open for 2008-2009 Flu Season
- Akorn Inc. And CSL Biotherapies Sign a Specialty Distributor Agreement for Afluria(R) (Flu Vaccine)
- CSL Biotherapies Announces FDA Marketing Approval of Afluria(R)
- Influenza, Obesity, Bioterrorism, Prescription Drugs, EnvironmentalThreats Among Top Public Health Concerns at APHA Meeting Nov. 6-10
- HHS Cites Tamiflu in New Antiviral Guidelines for Preventing, Treating Influenza
- Asia Is Traditional Cradle of Influenza Pandemics
- Researchers Model Evolution of Influenza Virus
Rating: 2.0 / 5 (3 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds